Carilizumab
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma (NCT04588987) | Sun Yat-sen University | 2020-10-01 |
Track Carilizumab automatically
Every clearance here is in the API, with alerts when new ones post.